Explore

Neuroscience research is advancing what we know about depression, and helping us develop treatments for it.
  • BrainFacts/SfN
The risks of antidepressants during pregnancy are minimal — and they pale in comparison to the risks of not treating depression.
  • BrainFacts/SfN
The first new antidepressant medication in decades, ketamine is a game changer for depression treatment.
  • BrainFacts/SfN
  • 5 min
Around the world, women are more likely than men to be diagnosed with depression.
  • BrainFacts/SfN
AI programs assist clinicians in surfacing signs of depression through patient data.
  • BrainFacts/SfN
Chance observations in the 1950s prompted scientists to hypothesize that low neurotransmitter levels cause depression. That thinking has unraveled.
  • Knowable Magazine
The fast-acting drug offers a new way to treat depression and fathom its origins. Recent approval of a nasal spray promises to expand access, but much remains unknown.
  • Knowable Magazine
Serendipitous findings in the 1950s spawned the idea that depression was a “chemical imbalance” in the brain. But decades of research — and a radical new treatment — are upending that thinking.
  • BrainFacts/SfN
Depression does not only affect how people feel – it can also change how they think.
  • BrainFacts/SfN
Hormonal changes following delivery, coupled with the added stress of caring for an infant round-the-clock, make the postpartum a time of heightened vulnerability to depression.
  • BrainFacts/SfN
The researcher discusses potential risk factors for depression and schizophrenia.
  • People Behind the Science
  • 33 min
People who react strongly to placebos also react strongly to antidepressants, and vice versa, according to new research.
  • The Dana Foundation